Bacterial Profile and Their Antimicrobial Susceptibility Pattern of Isolates Recovered from Intensive Care Unit Environments at Wachemo University Nigist Ellen Mohammed Memorial Comprehensive Specialized Hospital, Southern Ethiopia

Table 4

Multidrug-resistance pattern of bacterial isolates from ICU environments at Wachemo University Nigist Ellen Mohammed Memorial Comprehensive Specialized Hospital, August 1, 2022, to October 30, 2022.

Multidrug-resistance profiles of Gram-negative isolates
Bacterial isolates and MDR profiles	Frequency n (%)
E. coli
NIT, CIP, CXT, CN, MER, CTR, COT, AMP	2 (4.9%)
CIP, CAZ, AMC, CHL, CXM, MER, COT	2 (4.9%)
CXT, CAZ, AMC, CN, CHL, COT, AMP	1 (2.4%)
CIP, CXT, CAZ, MER, COT, AMP	3 (7.3%)
CAZ, AMC, CN, CHL, CTR, AMP	2 (4.9%)
NIT, CXT, CTR, COT, AMP, TE	1 (2.4%)
CXT, MER, CTR, COT, AMP	4 (9.8%)
CAZ, AMC, CHL, MER, COT	2 (4.9%)
CIP, CAZ, CXM, CTR, COT	2 (4.9%)
CXT, CN, MER, CTR, TE	1 (2.4%)
CXT, CAZ, MER, CTR	6 (14.6%)
CAZ, CN, CHL, AMP	5 (12.2%)
CIP, CTR, AMP	4 (9.8%)
Total	35/41 (85.4%)
K. pneumoniae
NIT, CIP, CXT, AMC, MER, CTR, COT, AMP	4 (13.4%)
CIP, CXT, CAZ, CN, CHL, COT, AMP	2 (6.7%)
CIP, AMC, MER, CTR, COT, AMP, TE	2 (6.7%)
NIT, CAZ, CN, CHL, COT, AMP	1 (3.35%)
CAZ, AMC, CXM, COT, AMP	1 (3.35%)
CXT, MER, AMP, TE	6 (20%)
AMC, CXM, MER, COT	3 (10%)
CIP, COT, TE	3 (10%)
Total	22/30 (73.3%)
P. aeruginosa
CIP, CAZ, AMC, CHL, MER, TE	4 (30.8%)
NIT, CXT, CN, COT, AMP	2 (15.4%)
CAZ, AMC, CTR, AMP, TE	1 (7.7%)
CHL, CTR, COT	1 (7.7%)
CIP, CXT, MER	1 (7.7%)
Total	9/13 (62.2%)
A. baumannii
AMC, CAZ, CXM, CTR, COT, AMP, TE	3 (27.3%)
CIP, CXT, AMC, MER	2 (18.2%)
NIT, CAZ, CTR, COT	2 (18.2%)
CXT, CN, CTR	1 (9.1%)
COT, AMP, TE	1 (9.1%)
Total	9/11 (82.2%)
Enterobacter species
CIP, CAZ, AMC	1 (16.7%)
CHL, MER, COT	1 (16.7%)
AMC, CTR, AMP	1 (16.7%)
Total	3/6 (50%)
Salmonella species
CIP, AMC, CTR, COT	1 (25%)
MER, AMP, TE	1 (25%)
Total	2/4 (50%)
CoNS
CIP, CXT, CLN, AZM, MET, CLX, COT, TE	2 (%)
NIT, CIP, VAN, CN, CHL, CLX, COT, AMP	1 (1.4%)
CIP, CXT, CN, AZM, MET, COT, TE	3 (4.2%)
CXT, CHL, CLX, COT, AMP	7 (9.7%)
CIP, CN, CLX, AMP	7 (9.7%)
CXT, CLN, VAN, AZM	4 (5.6%)
CLX, COT, AMP	9 (9.7%)
CIP, CXT, TE	6 (8.3%)
Total	39/72 (54.2%)
S. aureus
NIT, CIP, CXT, AZM, CLX, MET, COT, AMP	4 (6.6%)
CIP, CXT, CLN, VAN, CN, CHL, AZM	2 (3.3%)
NIT, CIP, CN, CHL, COT, AMP, TE	1 (1.6%)
CXT, CLN, CLX, MET, COT, TE	3 (4.9%)
NIT, CIP, CXT, VAN, CN, TE	2 (3.3%)
CXT, AZM, CLX, COT, AMP	6 (9.8%)
CIP, CXT, COT, AMP	6 (9.8%)
NIT, CLX, MET, TE	4 (6.6%)
CIP, COT, AMP	9 (14.8%)
CLN, CN, MET	3 (4.9%)
Total	40/61 (65.6%)
Total MDR isolates	159/238 (66.8%), (95% CI = (60.8, 72.78))